Management Team

Paul Blake, FRCP

Founder & CEO

• 30+ years management and drug development experience
• Numerous NDA/sNDA/MAA approvals, including three entirely novel indications
• Former Chief Development Officer at Oxford Biomedica
• Former Executive VP of Worldwide Medical and Regulatory Operations at Cephalon
• Former Chief Medical Officer and Senior VP of Clinical R&D at SmithKline Beecham

Hani Gabra, PhD FRCP

Founder & CSO

• Internationally-recognized translational medical oncologist and gynecologic cancer expert with 30+ years of academic experience
• Professor Emeritus in Medical Oncology at Imperial College London
• Visiting Professor at the Center for Cancer Biomarkers at University of Bergen
• Former VP in early clinical development at Astra Zeneca
• Former CMO and head of clinical development at BerGenBio AS

Dan Soland

COO

• VP at Glaxosmithkline Biologicals
• President Chiron Vaccines
• COO at Viropharma
• CEO Uniqure N.V.
• Independant board member at Acadia Pharmaceuticals and DBV Technologies

Adam Marsh, PhD

VP Biomarker Development

• Professor computational biology – University of Delaware
• CSO at Genome Profiling LLC